Nick Cammack

3.1k citations
42 papers · 2.2k indexed · h-index 28
Topics
HIV/AIDS drug development and treatment (32 papers)HIV Research and Treatment (25 papers)Hepatitis C virus research (16 papers)

In The Last Decade

Nick Cammack

42 papers receiving 2.1k citations

Peers

Nick Cammack
Comparison fields: 5 of 79
  • Infectious Diseases 1.4k
  • Hepatology 927
  • Virology 890
  • Epidemiology 807
  • Molecular Biology 557
Replace Donald J. Graham with:
Donald J. Graham United States
Isabel Nájera United States
George Kukolj Canada
Donald R. O’Boyle United States
Kai Lin United States
Manuel Tsiang United States
R. Clayton United Kingdom
Zuzana Hostomska United States
Mike Westby United Kingdom
M. Michelle Berrey United States
Nick Cammack relative to Donald J. Graham United States Donald J. Graham's profile →
Citations per field
00.5×2.8×
Donald J. Graham · 1×
Citations per year

Countries citing papers authored by Nick Cammack

Since Specialization
Citations

This map shows the geographic impact of Nick Cammack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Cammack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Cammack more than expected).

Fields of papers citing papers by Nick Cammack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Cammack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Cammack. The network helps show where Nick Cammack may publish in the future.

Co-authorship network of co-authors of Nick Cammack

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Cammack. A scholar is included among the top collaborators of Nick Cammack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Cammack. Nick Cammack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 43
2 11
3 71
4 22
5 21
6 132
7 42
8 20
9 101
10 23
11 42
12 52
13 56
14 42
15 13
16 52
17 26
18 18
19 28
20 45

About Nick Cammack

Nick Cammack is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 42 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (32 papers), HIV Research and Treatment (25 papers) and Hepatitis C virus research (16 papers). The work is most often cited by research in Virology (890 citations), Hepatology (927 citations) and Infectious Diseases (1.4k citations). Nick Cammack has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Isabel Nájera, Klaus Klumpp, Sonal Rajyaguru, Sophie Le Pogam, Julian Symons, Vincent Lévêque, Wen-Rong Jiang, Hyunsoon Kang, Matthew F. McCown and Samir Ali. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026